NCI | GenomeWeb

NCI

The research used multiple genetic analyses on samples collected over 29 years to show changes associated with disease progression.

Grade 3 breast tumors generally have worse prognoses, but SEER data showed that Oncotype DX can identify a large proportion of patients who do well without chemo.

KRAS in its Sights

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The collaborators aim to build an artificial intelligence network that will support Vice President Joe Biden's Cancer Moonshot initiative.

The company will expand its Cancer Genomics Cloud Pilot to include additional data sources such as the NCI's Genomic Data Commons, and improve its usability.

The company is working with the University of Florida Health Cancer Center to validate its RadTox QuantiDNA test as a monitor of cfDNA in patient plasma.

Slow Report

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

Non-randomized studies have downsides, but researchers say they are a way to gather incremental evidence on precision oncology approaches without denying patients access.

The NCI Genomic Data Commons was launched this summer to  to centralize, standardize, and make available genomic and molecular data from various research programs.

The partners have committed to analyzing coding mutations, driver non-coding mutations, and structural variations across tumor types for the project.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.